首页> 外国专利> INHIBITION OF ANGIOGENESIS AND DESTRUCTION OF ANGIOGENIC VESSELS WITH EXTRACTS OF NONI JUICE (MORINDA CITRIFOLIA)

INHIBITION OF ANGIOGENESIS AND DESTRUCTION OF ANGIOGENIC VESSELS WITH EXTRACTS OF NONI JUICE (MORINDA CITRIFOLIA)

机译:诺尼果汁提取物对柑橘血管生成的抑制作用及对血管的破坏作用

摘要

Noni juice and a protein-free, alcohol precipitate of Noni juice inhibitedangiogenesis in in vitro human angiogenesis models. When growth mediumcontained Noni juice at least over the range from about 2.5% to about 33% (byvolume), angiogenesis was blocked. Moreover, Noni juice and an ethanolprecipitate were able to destroy a pre-existing angiogenic response as well asprevent the development of new vessels. Noni juice was effective in inhibitingthe growth of angiogenic vessels from breast cancer explants. It will also beeffective in treating cancers and non-cancerous diseases whose responseincludes an increase in angiogenesis, e.g., retinopathy of prematurity,neovascular glaucoma, diabetic retinopathy, and psoriasis. The primaryantiangiogenic component is believed to be a carbohydrate with a molecularweight less than about 6000 Daltons. In an initial experiment, oraladministration of Noni juice appeared to adversely affect the antioangiogeniccomponent(s) in the juice.
机译:诺丽果汁和诺丽果汁的无蛋白酒精沉淀得到抑制体外人类血管生成模型中的血管生成。当生长培养基所含诺丽果汁至少在约2.5%至约33%的范围内体积),血管生成被阻止。此外,诺丽果汁和乙醇沉淀物能够破坏先前存在的血管生成反应以及防止新船的发展。诺丽果汁有效抑制乳腺癌外植体中血管生成血管的生长。也将是有效治疗癌症和非癌性疾病的反应包括血管生成增加,例如早产儿视网膜病变,新生血管性青光眼,糖尿病性视网膜病变和牛皮癣。首要的抗血管生成成分被认为是一种碳水化合物,具有重量小于约6000道尔顿。在最初的实验中,口服服用诺丽果汁似乎对抗血管生成有不利影响果汁中的成分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号